Harm Sinnige

3.6k citations
29 papers · 2.2k indexed · 1 hit paper · h-index 11

Harm Sinnige

27 papers receiving 2.1k citations

Hit Papers

Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Co...1.0k20092026201420202505007501000

Peers

Harm Sinnige
Comparison fields: 5 of 87
  • Oncology 1.6k
  • Hepatology 416
  • Hematology 436
  • Pathology and Forensic Medicine 402
  • Pulmonary and Respiratory Medicine 569
Replace M. Flesch with:
M. Flesch France
Martin Šmakal United States
Jean-Luc Canon Belgium
D. Voliotis Germany
N. Schleucher Germany
M Krulik France
Allert H. Vos Netherlands
Jane Robertson United Kingdom
J. T. Hartmann Germany
Daniel Hendler Israel
Harm Sinnige relative to M. Flesch France M. Flesch's profile →
Citations per field
00.5×1.5×2.0×
M. Flesch · 1×
Citations per year

Countries citing papers authored by Harm Sinnige

Since Specialization
Citations

This map shows the geographic impact of Harm Sinnige's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harm Sinnige with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harm Sinnige more than expected).

Fields of papers citing papers by Harm Sinnige

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harm Sinnige. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harm Sinnige. The network helps show where Harm Sinnige may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Harm Sinnige, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Harm Sinnige Line = papers co-authored together Harm Sinnige links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 2019119
2 20179
3 20167
4 20136
5 20131
6 20127
7 201129
8 2011125
9 201011
10 200835
11 200810
12 2007461
13 200724
14 200449
15 200324
16
[Three patients with massive pulmonary embolism].
20020
17 19954
18 19939
19 19925
20 19905

About Harm Sinnige

Harm Sinnige is a scholar working on Hematology, Oncology, Genetics, Hepatology and Pathology and Forensic Medicine, having authored 29 papers that have together received 2.2k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (10 papers), Cancer Treatment and Pharmacology (9 papers), Multiple Myeloma Research and Treatments (8 papers), Gastric Cancer Management and Outcomes (5 papers), Acute Lymphoblastic Leukemia research (4 papers), Chronic Lymphocytic Leukemia Research (3 papers), Genetic factors in colorectal cancer (3 papers) and Chronic Myeloid Leukemia Treatments (3 papers). The work is most often cited by research in Oncology (1.6k citations), Hepatology (416 citations), Hematology (436 citations), Pathology and Forensic Medicine (402 citations) and Pulmonary and Respiratory Medicine (569 citations). Harm Sinnige has collaborated with scholars based in Netherlands, Belgium and United States. Frequent co-authors include Cornelis J.A. Punt, Miriam Koopman, Linda Mol, Frans Erdkamp, Otilia Dalesio, C. J. Rodenburg, Ninja Antonini, G.J. Creemers, Jolanda Schrama and Annemieke Cats. Their work appears in journals such as Blood, Annals of Hematology, European Journal of Cancer, Haematologica and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026